Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Intensive Manufacturing Programme Case Study Released

The GMP Manufacturing team at Arcinova are always looking at agile ways to manufacture and deliver high quality clinical supplies for their clients. This case study illustrates how Arcinova were able to offer the necessary innovation and manufacturing expertise to support our customers rigorous timelines, quality and quantity requirements.

Find out more here

#CaseStudy #DrugProduct


Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.